| 1002 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Violent Deaths in America | CDC Features |
Violence is a significant public health problem. Each year, violence kills 55,000 people in the United States. The National Violent Death Reporting System provides a clearer understanding of violent deaths so we can prevent them. |
| Violent Death Reporting | 0.804023 |
| CDC | 0.345268 |
| medical examiner | 0.405583 |
| homicide | 0.322663 |
| youth | 0.320067 |
| Disease Control | 0.407278 |
| social services | 0.411347 |
| homes | 0.319042 |
| businesses | 0.319031 |
| knowledge | 0.317996 |
| National Center | 0.40802 |
| circumstances | 0.319256 |
| state-based surveillance | 0.412256 |
| violent deaths | 0.923971 |
| prevention programs | 0.404114 |
| community | 0.319243 |
| successful violence prevention | 0.574201 |
| particular toll | 0.416889 |
| vast proportions | 0.423028 |
| fabric | 0.320111 |
| important public | 0.409046 |
| local violence prevention | 0.57701 |
| NVDRS states | 0.411317 |
| coroner | 0.323033 |
| kills | 0.357493 |
|
| Centers | 0.318878 |
| Injury Prevention | 0.411242 |
| United States | 0.526474 |
| age group | 0.414397 |
| young people | 0.414118 |
| time outdoors | 0.408312 |
| facts | 0.337603 |
| law enforcement problem | 0.514036 |
| U.S. | 0.318789 |
| police reports | 0.404753 |
| value | 0.319057 |
| violence | 0.708661 |
| anonymous database | 0.401005 |
| significant public health | 0.524979 |
| information—from death certificates | 0.489351 |
| different sources | 0.405625 |
| groups | 0.317938 |
| NVDRS data help | 0.491211 |
| continued expansion | 0.404359 |
| Fear | 0.318059 |
| public health problem | 0.721058 |
| clearer understanding | 0.546712 |
| ages | 0.319707 |
| National Violent Death | 0.797425 |
|
CLICK HERE |
| 5208 |
Centers for Disease Control and Prevention |
Html |
en |
Science Clips - Monday, March 14, 2011 |
null |
| Sex Transm Dis. | 0.928666 |
| trivalent influenza vaccine | 0.874443 |
| Antimicrob Agents Chemother. | 0.921974 |
| Global proficiency study | 0.866565 |
| salmonella serotype Saintpaul | 0.86379 |
| Gottlieb SL | 0.867843 |
| non-fatal inhalation anthrax | 0.866349 |
| ACUITY trial substudy | 0.87845 |
| CDC Science Clips | 0.968589 |
| McRee AL | 0.877105 |
| transcriptase M184V mutation | 0.865102 |
| quality control materials | 0.863917 |
| Chief Science Officer | 0.876829 |
| birth certificate reports | 0.866361 |
| Allergy Clin Immunol. | 0.871003 |
| human papillomavirus | 0.935957 |
| Reiter PL | 0.870685 |
| Public Health Rep. | 0.887618 |
| BMC Public Health. | 0.874792 |
| Stephen B. Thacker | 0.932793 |
| human papillomavirus vaccine | 0.896957 |
| Thromb Thrombolysis. | 0.876754 |
| Mar | 0.950199 |
| Hooper WC | 0.879178 |
| United States | 0.920717 |
|
| lysosomal storage disease | 0.869835 |
| Texas restaurant investigations | 0.865307 |
| Human papillomavirus genotype | 0.878872 |
| respiratory disease prevention | 0.865761 |
| acute coronary syndromes | 0.92146 |
| Stone GW | 0.87624 |
| cross-sectional worldwide study | 0.867979 |
| quadrivalent HPV vaccine | 0.871457 |
| Occup Environ Med. | 0.865246 |
| young Ugandan children | 0.864645 |
| sexual risk behavior | 0.866383 |
| individual participant data | 0.865144 |
| prospective cohort study | 0.866804 |
| mutation-specific minority assays | 0.863663 |
| unrecognized transmitted drug | 0.866319 |
| public health literature | 0.878485 |
| B. Thacker CDC | 0.957275 |
| human papillomavirus vaccination | 0.876799 |
| birth defects | 0.866237 |
| cervical intraepithelial neoplasia | 0.907685 |
| UK surveillance study | 0.87703 |
| Clin Vaccine Immunol. | 0.888059 |
| et al | 0.875123 |
| PLoS Med. | 0.878247 |
|
CLICK HERE |
| 5982 |
Centers for Disease Control and Prevention |
Html |
en |
Tetrahydrofuran - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6027 |
Centers for Disease Control and Prevention |
Html |
en |
Ketene - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 7140 |
Centers for Disease Control and Prevention |
Html |
en |
Global Health - Turkey |
null |
| Content source | 0.422709 |
| HHS | 0.297574 |
| list Skip | 0.74332 |
| endorsement | 0.291872 |
| CDC | 0.271556 |
| non-federal site | 0.4688 |
|
| Notice | 0.270187 |
| sponsors | 0.241885 |
| page options Skip | 0.947337 |
| information | 0.241652 |
| employees | 0.242118 |
|
CLICK HERE |
| 7844 |
Centers for Disease Control and Prevention |
Html |
en |
Lead Poisoning in Children - Health Communication |
Lead Poisoning in Children - Gateway to Health Communication - CDC |
| lead poisoning need | 0.563662 |
| naturally occurring element | 0.50395 |
| body | 0.340628 |
| lead-containing paint | 0.399945 |
| children | 0.653993 |
| U.S. children | 0.412469 |
| low levels | 0.401148 |
| ethnic groups | 0.394696 |
| young children | 0.492455 |
| older housing | 0.390021 |
| neurobehavioral development | 0.407907 |
| automobile batteries | 0.394742 |
| lead-based paint | 0.504474 |
| paint chips | 0.399584 |
| greatest risk | 0.392158 |
| old paint | 0.394278 |
| lead sources | 0.417178 |
| Health officials | 0.388836 |
| lead-contaminated dust | 0.405817 |
| lead poisoning | 0.904451 |
| stained-glass windows | 0.40182 |
| Yes. The key | 0.396317 |
| decreased intelligence | 0.412179 |
| lead exposure | 0.49606 |
| special precautions | 0.392406 |
|
| Lead-based paints | 0.417058 |
| renovation | 0.33282 |
| United States | 0.412605 |
| significant sources | 0.396571 |
| high levels | 0.401808 |
| kidneys | 0.322546 |
| local health department | 0.469401 |
| adverse health effects | 0.501931 |
| abdominal pain | 0.389767 |
| older houses | 0.390515 |
| U.S. housing | 0.395363 |
| health care | 0.3928 |
| Mexican-Americans | 0.322535 |
| Lead hazards | 0.422864 |
| economic strata | 0.399842 |
| two-year-old son | 0.399172 |
| blood | 0.357407 |
| distinctive clinical symptoms | 0.486898 |
| doctor | 0.357516 |
| leaded dust | 0.40004 |
| convulsions | 0.326217 |
| appropriate safety measures | 0.465314 |
| childhood lead poisoning | 0.59005 |
| family | 0.357529 |
|
CLICK HERE |
| 8738 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease | Incarceration of a HouseholdMember and Hispanic Health Disparities: Childhood Exposure andAdult Chronic Disease Risk Behaviors - CDC |
Incarceration of a household member has been linked to poor mental and behavioral health outcomes in children, but less is known about the health behaviors of these children once they reach adulthood. |
| incarceration | 0.293643 |
| childhood | 0.21655 |
|
| incarcerated household member | 0.911709 |
|
CLICK HERE |
| 9521 |
Centers for Disease Control and Prevention |
Html |
en |
Diagnosis of Anthrax |
Doctors rarely see a patient with anthrax but CDC guidance and case definitions are available to help them diagnose the infection. |
| chest X-rays | 0.515659 |
| case definitions | 0.478066 |
| diagnostic tests | 0.461534 |
| United States | 0.492018 |
| patients | 0.242131 |
| inhalation anthrax | 0.982551 |
| pleural effusion | 0.566327 |
| Anthrax diagnosis | 0.736559 |
| X-ray findings | 0.480633 |
|
| exposure | 0.26226 |
| mediastinal widening | 0.556798 |
| doctors | 0.349645 |
| Samples | 0.242223 |
| CDC Guidance | 0.504424 |
| antibiotics | 0.272915 |
| CT scans | 0.475922 |
| patient histories | 0.456309 |
|
CLICK HERE |
| 11281 |
Centers for Disease Control and Prevention |
Html |
en |
Case Definition for Ebola Virus Disease (EVD) |
null |
| healthcare personnel | 0.511928 |
| consistent signs | 0.532941 |
| country | 0.419892 |
| CDC | 0.422762 |
| PPE | 0.43344 |
| Ebola virus infection | 0.805453 |
| uncertain control measures | 0.629843 |
| droplet precautions | 0.53499 |
| National Notifiable Disease | 0.671942 |
| infection control | 0.663512 |
| NNDSS | 0.423023 |
| urban settings | 0.521701 |
| Ebola virus | 0.97283 |
| Health-care providers | 0.541111 |
| state health department | 0.615194 |
| patient | 0.438106 |
| contact | 0.457063 |
| widespread Ebola virus | 0.772897 |
| deadly viral illness | 0.669694 |
| personal protective equipment | 0.610097 |
| cases | 0.419831 |
|
| PUI | 0.439177 |
| need | 0.418939 |
| private bathroom | 0.515779 |
| testing | 0.437432 |
| patients | 0.421458 |
| Infection control personnel | 0.641306 |
| diagnosis | 0.419038 |
| Laboratory-confirmed diagnostic evidence | 0.630038 |
| history | 0.419936 |
| Early recognition | 0.652644 |
| symptoms | 0.420907 |
| U.S. states | 0.541223 |
| EVD | 0.53396 |
| territories | 0.426936 |
| Surveillance | 0.421841 |
| epidemiologic risk | 0.533283 |
| Healthcare providers | 0.519112 |
| page | 0.419329 |
| consultation | 0.419028 |
| single room | 0.516188 |
| travel | 0.419918 |
|
CLICK HERE |
| 11560 |
Centers for Disease Control and Prevention |
Html |
en |
Avian Influenza (Bird Flu) Research |
This factsheet describes CDC's avian influenza (bird flu) research and its public health impact. |
| important public health | 0.340919 |
| life sciences research | 0.33479 |
| public health policy | 0.33778 |
| genetic characterization | 0.353137 |
| amino acids | 0.350613 |
| Antigenic characterization data | 0.3424 |
| newly emerging bird | 0.339448 |
| new vaccine viruses | 0.390748 |
| CDC experts | 0.339974 |
| different flu viruses | 0.475557 |
| specific bird flu | 0.433703 |
| human health | 0.33589 |
| vaccine viruses | 0.396646 |
| CDC flu laboratorians | 0.438371 |
| flu virus samples | 0.428012 |
| CDC Influenza Division | 0.362738 |
| flu antiviral medications | 0.42419 |
| dual use research | 0.340245 |
| bird flu viruses | 0.920729 |
| public health | 0.444963 |
| CDC research | 0.341365 |
| antigenic characterization page | 0.341548 |
| threat bird flu | 0.444509 |
| World Health Organization | 0.367373 |
|
| antiviral resistance | 0.344821 |
| public health purpose | 0.339934 |
| bird flu vaccines | 0.429307 |
| public health precautions | 0.339785 |
| bird flu virus | 0.47049 |
| flu illness | 0.397463 |
| CDC researchers | 0.340114 |
| flu antiviral drugs | 0.495872 |
| testing antiviral drugs | 0.350637 |
| global flu surveillance | 0.414232 |
| public health officials | 0.335845 |
| Flu researchers | 0.402416 |
| H9 viruses | 0.375664 |
| Antiviral resistance testing | 0.341514 |
| newer bird flu | 0.432897 |
| pandemic preparedness efforts | 0.334737 |
| human infections | 0.36044 |
| antigenic characterization | 0.431564 |
| bird flu research | 0.433235 |
| FDA-approved flu | 0.398919 |
| public health laboratories | 0.334622 |
| bird flu test | 0.418275 |
| H5N1 bird flu | 0.418624 |
|
CLICK HERE |